Overview of HIV Drugs MarketThe Global HIV Drugs Market is valued at USD 34.75 Billion in 2024 and is projected to reach a ...

Experts advise on how country can build sustainable systems ANALYSIS | IAN KATUSIIME | When U.S. President Donald Trump on ...

Experts advise on how country can build sustainable systemsWhen U.S. President Donald Trump on March 06 announced aid suspension to South Africa over a disagreement, it was a vindication for the ...

The National Agency for the Control of AIDS (NACA) has assured Nigerians, particularly those living with HIV, that there is no shortage of antiretroviral drugs in the country. In response to ...

Lenacapavir, a once-a-year injection, can treat HIV, prevent transmission and stop new infections — all with a single shot.

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

No significant association was observed between viremia history during ART and CVD risk in a large international cohort of patients with HIV infection.

However, owing to the limited pharmacokinetics and biodistribution of HIV antiretroviral drugs, sanctuary sites develop where the virus can persist. This not only makes eradication of the virus ...

In a shocking revelation, nine persons who shared syringes for infusing drugs have been found to be carriers of HIV at Valanchery in Malappuram district of Kerala. Health authorities confirmed ...

Social barriers were linked to reduced access and low uptake of LAI PrEP and ART for HIV treatment and prevention.

Lamivudine oral tablet is a generic prescription drug used to treat HIV alongside other antiretroviral drugs, and to treat long-term hepatitis B. It’s usually taken once or twice per day.